Presentation is loading. Please wait.

Presentation is loading. Please wait.

Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S

Published byKevin Fields Modified over 6 years ago

Similar presentations

Presentation on theme: "Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S"— Presentation transcript:

1 Outcomes for Lung Transplantation for Lung Cancer in the United Network for Organ Sharing Registry 
Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S. Bryant, MSPH, MD, Anthony W. Kim, MD, MS, Jasleen Kukreja, MD, MPH, David P. Mason, MD, Christian A. Bermudez, MD, Frank C. Detterbeck, MD, Daniel J. Boffa, MD  The Annals of Thoracic Surgery  Volume 94, Issue 3, Pages (September 2012) DOI: /j.athoracsur Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival is shown for the bronchoalveolar carcinoma (BAC)/cancer cohort (dashed line; n = 29) compared with the general lung transplantation cohort (solid line; n = 21,524). (HR = hazard ratio.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall survival is shown for bronchoalveolar carcinoma/cancer patients with invasive (dashed line; n = 13) or noninvasive (solid line; n = 14) tumors. (HR = hazard ratio.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Overall survival is shown for bronchoalveolar carcinoma/cancer patients in the presence (dashed line; n = 7), or absence (solid line; n = 20) of lymph node (LN) metastases. (HR = hazard ratio.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S"

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Photodynamic Laser Therapy for Lesions in the Airway

Photodynamic Laser Therapy for Lesions in the Airway
What Predicts Long-Term Survival After Heart Transplantation

What Predicts Long-Term Survival After Heart Transplantation
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,
Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R

Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C

Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C
Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database 

Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database 
Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Similar presentations

Ads by Google